Solid Biosciences reported Q2 2026 financial results and a business update, outlining progress across operations and its development pipeline. The company also

Solid Biosciences reported Q2 2026 financial results and a business update, outlining progress across operations and its development pipeline. The company also pointed to ongoing research and community initiatives as it advances its programs.